All Industries

Top Therapeutics Companies

205 Therapeutics companies, sorted by total funding raised.

Spark TherapeuticsAcquired

Spark Therapeutics develops gene therapy treatments for debilitating genetic diseases; acquired b...

Philadelphia, United States201–500Biotech, Therapeutics
Series B·$72.8M·May 2014
Hydra Biosciences, Inc.Closed

Private biopharmaceuticals company pioneering the discovery of novel drugs using its expertise in...

Cambridge, United States11–50Biotech, Drug Discovery
Series E·$72.2M·Mar 2015
Delphia Therapeutics

Biotech developing 'activation lethality' cancer therapeutics that overactivate oncogenes to sele...

Cambridge, United States11–50Biotech, Therapeutics
Series A·$67.0M·May 2024
Bionaut Labs

Develops microscale wireless micro-robots to deliver therapies and diagnostics to deep body locat...

Los Angeles, United States11–50Biotech, Medical Devices
Extension Round·$63.2M·Feb 2024
Shasqi

Biotech company using click chemistry to selectively activate cancer drugs at the tumor site, imp...

San Francisco, United States11–50Biotech, Healthcare
Series B·$60.5M·Nov 2021
Surge Therapeutics

Develops an injectable intraoperative immunotherapy hydrogel to prevent post-surgical cancer recu...

Cambridge, United States1–10Biotech, Drug Discovery
Series B·$58.0M·Jul 2023
64x Bio

High throughput design of cells for therapeutics applications.

11–50Artificial Intelligence, Healthcare
Series A·$55.0M·Jan 2022
Appia BioClosed

Develops allogeneic CAR‑iNKT cell therapies from hematopoietic stem cells to treat cancers, partn...

Los Angeles, United States11–50Biotech, Drug Discovery
Series A·$52.0M·May 2021
Somite AI

AI company building foundation models for human stem cells to accelerate cell therapy development...

Boston, United States1–10Artificial Intelligence, Biotech
Series A·$47.5M·Jun 2025
Turnstone BiologicsClosed

Clinical-stage biotech developing Selected TIL (tumor-infiltrating lymphocyte) cell therapies for...

Ottawa, Canada51–200Biotech, Therapeutics
Series C·$42.1M·Mar 2019
Mindstate Design Labs

Next-generation psychedelic therapeutics for mental health

San Francisco, United States1–10Artificial Intelligence, Biotech
Venture Round·$37.2M·Nov 2024
ReceptosClosed

Biopharmaceutical company that developed immune-inflammatory therapies, notably ozanimod (RPC-106...

San Diego, United States51–200Biotech, Drug Discovery
Venture Round·$35.8M·Mar 2012
Permanence Bio

Developing therapeutics to stop mutations to prevent cancer

San Francisco, United States1–10Biotech, Drug Discovery
Series A·$35.0M·Jan 2026
Sorriso Pharmaceuticals

Sorriso Pharmaceuticals is a biotechnology company advancing a pipeline of disease-modifying anti...

Sandy, United States1–10Biotech, Drug Discovery
Series A·$31.0M·Dec 2021
Fate TherapeuticsIPO

Clinical-stage biopharmaceutical company developing iPSC-derived cellular immunotherapies for aut...

La Jolla, United States51–200Biotech, Healthcare
Series B·$30.0M·Nov 2009
RZ Nomics

Rznomics is a South Korean RNA therapeutics biotech developing gene therapies for cancer, degener...

Yongin, South Korea11–50Biotech, Therapeutics
Series C·$30.0M·Jan 2023
Moonwalk Biosciences

Develops precision epigenetic medicines targeting adipose biology and cardiometabolic disease usi...

South San Francisco, United States11–50Biotech, Drug Discovery
Seed·$28.5M·Jan 2024
Scioto BiosciencesAcquired

Scioto is a preclinical stage company developing innovative therapies devoted to having a transfo...

Indianapolis, United States1–10Food & Beverage, Biotech
Series B·$28.3M·Aug 2020
Function Oncology

Develops a CRISPR-powered personalized functional genomics platform to profile patient tumors and...

San Diego, United States1–10Biotech, Diagnostics
Series A·$28.0M·Apr 2023
TwoStep Therapeutics

A versatile integrin-binding peptide, PIP

San Carlos, United States1–10Biotech, Drug Discovery
Series A·$27.6M·Jan 2026
Westlake Therapeutics

Biotech developing engineered red blood cell therapeutics for cancer, immunological, and metaboli...

Hangzhou, ChinaBiotech, Therapeutics
Series A·$27.6M·Jun 2022
StromedixAcquired

Biotechnology company developing innovative therapies for fibrosis and organ failure.

Cambridge, United States1–10Biotech, Therapeutics
Series C·$25.0M·Jan 2011
AmgenIPO

Develops and manufactures biologic medicines treating serious illnesses and improving patient out...

Thousand Oaks, United States10001+Biotech, Healthcare
Venture Round·$19.0M·Apr 1980
Aenitis Technologies

Separation and filtration of biological elements via acoustic technologies.

Paris11–50Biotech, Medical Devices
Venture Round·$16.9M·Oct 2024
American Gene Technologies

Gene and cell therapeutics company using a proprietary lentiviral platform for infectious disease...

Rockville, United States11–50Biotech, Therapeutics
Series D·$16.0M·Jan 2018